Skip to main content
Top
Published in: Journal of Nuclear Cardiology 6/2019

01-12-2019 | Editorial

Are you stressed?

Authors: C. Rischpler, MD, M. Totzeck, MD

Published in: Journal of Nuclear Cardiology | Issue 6/2019

Login to get access

Excerpt

Myocardial perfusion imaging is still a mainstay for the diagnosis and management of coronary artery disease. As a consequence, millions of US patients are examined with this technique every year.1 There are crucial points regarding the conduction of the procedure in order to guarantee optimal patient preparation, image quality, and analysis. Among those critical points are the choice and dose of the radiotracer, ECG-gated testing (for the assessment of left ventricular volumes and ejection fraction) and the compulsory quantification of the extent of affected myocardium (scar vs. ischemia, percentage of the left ventricular myocardium). (More details on state-of-the-art myocardial perfusion imaging can be found in the respective guidelines as released, e.g., by ASNC, SNMMI, or EANM).2 Another utterly important point regarding the conduction of myocardial perfusion imaging tests is that patients are recommended to be stressed adequately.3 Whenever possible, physical exercise using either a treadmill or a bicycle ergometer should be the preferred method. If the patient is unable to exercise adequately, pharmacological agents to increase myocardial blood flow sufficiently to detect hemodynamically relevant coronary stenoses can be applied with comparable sensitivity and specificity.4,5 Currently, the most frequently used pharmacological stressors are regadenoson and adenosine. These substances bind to the adenosine receptor A2A in coronary arteries and initiate a dilatation of these vessels, which, in turn, increases myocardial blood flow up to fourfold. Dipyridamole acts via the same axis by an increase of intrinsic adenosine (through the inhibition of the cellular reuptake of adenosine into platelets, red blood cells, and endothelial cells). Unfortunately, all of these pharmacological stressors may have considerable side effects: Adenosine also binds to other adenosine receptor subtypes, which may result in significant arrhythmias (e.g., AV block and other arrhythmias), dilatation of peripheral vessels, hypotension, reflex tachycardia, and bronchoconstriction. Regadenoson is thought to have less side effects as it binds to the other adenosine receptor subtypes with lower affinity. The only infrequently used pharmacological stressor in myocardial perfusion imaging is dobutamine. Dobutamine is a sympathomimetic drug and is used in patients with severe COPD or asthma as it does not cause bronchoconstriction. …
Literature
1.
go back to reference 2008 Nuclear Medicine: Market Summary Report. Des Plains: IMV Medical Information Division; 2008. p. IV19-30. 2008 Nuclear Medicine: Market Summary Report. Des Plains: IMV Medical Information Division; 2008. p. IV19-30.
2.
go back to reference Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. 2016;23:606–39.CrossRef Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. 2016;23:606–39.CrossRef
3.
go back to reference Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol. 1989;14:1477–86.CrossRef Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol. 1989;14:1477–86.CrossRef
4.
go back to reference Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. J Am Coll Cardiol. 1992;19:248–57.CrossRef Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. J Am Coll Cardiol. 1992;19:248–57.CrossRef
5.
go back to reference Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: A multicenter, prospective, crossover trial. J Am Coll Cardiol. 1992;20:265–75.CrossRef Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: A multicenter, prospective, crossover trial. J Am Coll Cardiol. 1992;20:265–75.CrossRef
6.
go back to reference Tejani FH, Thompson RC, Kristy R, Bukofzer S. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: A prospective, randomized, multicenter study. Int J Cardiovasc Imaging. 2014;30:979–89.CrossRef Tejani FH, Thompson RC, Kristy R, Bukofzer S. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: A prospective, randomized, multicenter study. Int J Cardiovasc Imaging. 2014;30:979–89.CrossRef
7.
go back to reference Go RT, Marwick TH, MacIntyre WJ, Saha GB, Neumann DR, Underwood DA, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med. 1990;31:1899–905.PubMed Go RT, Marwick TH, MacIntyre WJ, Saha GB, Neumann DR, Underwood DA, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med. 1990;31:1899–905.PubMed
8.
go back to reference Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60:1828–37.CrossRef Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60:1828–37.CrossRef
9.
go back to reference Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J, et al. Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging. 2016;43:566–73.CrossRef Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J, et al. Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging. 2016;43:566–73.CrossRef
10.
go back to reference Jacobson AF, Cerqueira MD, Raisys V, Shattuc S. Serum caffeine levels after 24 hours of caffeine abstention: Observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine. Eur J Nucl Med. 1994;21:23–6.PubMed Jacobson AF, Cerqueira MD, Raisys V, Shattuc S. Serum caffeine levels after 24 hours of caffeine abstention: Observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine. Eur J Nucl Med. 1994;21:23–6.PubMed
11.
go back to reference Mishra RK, Dorbala S, Logsetty G, Hassan A, Heinonen T, Schelbert HR, et al. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. J Am Coll Cardiol. 2005;45:553–8.CrossRef Mishra RK, Dorbala S, Logsetty G, Hassan A, Heinonen T, Schelbert HR, et al. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. J Am Coll Cardiol. 2005;45:553–8.CrossRef
12.
go back to reference Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol. 2011;18:1086–94.CrossRef Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol. 2011;18:1086–94.CrossRef
13.
go back to reference Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, et al. Splenic switch-off: A tool to assess stress adequacy in adenosine perfusion cardiac MR imaging. Radiology. 2015;276:732–40.CrossRef Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, et al. Splenic switch-off: A tool to assess stress adequacy in adenosine perfusion cardiac MR imaging. Radiology. 2015;276:732–40.CrossRef
14.
go back to reference Morato M, Sousa T, Albino-Teixeira A. Purinergic receptors in the splanchnic circulation. Purinergic Signal. 2008;4:267–85.CrossRef Morato M, Sousa T, Albino-Teixeira A. Purinergic receptors in the splanchnic circulation. Purinergic Signal. 2008;4:267–85.CrossRef
15.
go back to reference Hosking A, Koulouroudias M, Zemrak F, Moon JC, Rossi A, Lee A, et al. Evaluation of splenic switch off in a tertiary imaging centre: Validation and assessment of utility. Eur Heart J Cardiovasc Imaging. 2017;18:1216–21.CrossRef Hosking A, Koulouroudias M, Zemrak F, Moon JC, Rossi A, Lee A, et al. Evaluation of splenic switch off in a tertiary imaging centre: Validation and assessment of utility. Eur Heart J Cardiovasc Imaging. 2017;18:1216–21.CrossRef
16.
go back to reference Liu A, Wijesurendra RS, Ariga R, Mahmod M, Levelt E, Greiser A, et al. Splenic T1-mapping: A novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017;19:1.CrossRef Liu A, Wijesurendra RS, Ariga R, Mahmod M, Levelt E, Greiser A, et al. Splenic T1-mapping: A novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017;19:1.CrossRef
17.
go back to reference Walkden M, Bryant J, Abbas A, Harden S, Shambrook J, Peebles C. Turning up the adenosine turns off the spleen. J Cardiovasc Magn Reson. 2015;17(Suppl 1):T1.CrossRef Walkden M, Bryant J, Abbas A, Harden S, Shambrook J, Peebles C. Turning up the adenosine turns off the spleen. J Cardiovasc Magn Reson. 2015;17(Suppl 1):T1.CrossRef
18.
go back to reference Klein-Wiele O, Sherifa W, Garmer M, Kara K, Gronemeyer D, Hailer B. Assessment of systemic adenosine effect using color doppler ultrasound of the splenic artery-feasibility and potential clinical utility for coronary interventions. Ultrasound Med Biol. 2018;44:1119–23.CrossRef Klein-Wiele O, Sherifa W, Garmer M, Kara K, Gronemeyer D, Hailer B. Assessment of systemic adenosine effect using color doppler ultrasound of the splenic artery-feasibility and potential clinical utility for coronary interventions. Ultrasound Med Biol. 2018;44:1119–23.CrossRef
20.
go back to reference Kuijpers D, van Dijk R, van Assen M, Kaandorp TAM, van Dijkman PRM, Vliegenthart R, et al. Disagreement between splenic switch-off and myocardial T1-mapping after caffeine intake. Int J Cardiovasc Imaging. 2018;34:625–32.CrossRef Kuijpers D, van Dijk R, van Assen M, Kaandorp TAM, van Dijkman PRM, Vliegenthart R, et al. Disagreement between splenic switch-off and myocardial T1-mapping after caffeine intake. Int J Cardiovasc Imaging. 2018;34:625–32.CrossRef
21.
go back to reference American Society of Nuclear Cardiology/MedAxiom Nuclear Survey 2013. J Nucl Cardiol 2014;21:5-88. American Society of Nuclear Cardiology/MedAxiom Nuclear Survey 2013. J Nucl Cardiol 2014;21:5-88.
Metadata
Title
Are you stressed?
Authors
C. Rischpler, MD
M. Totzeck, MD
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 6/2019
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-1332-6

Other articles of this Issue 6/2019

Journal of Nuclear Cardiology 6/2019 Go to the issue